Clinical Updates
Drug approvals, guideline changes, and treatment advances
Creatine and Hair Loss: A 16-Year Myth Debunked by First Rigorous Trial
A 16-year-old claim that creatine causes hair loss, based on a single 2009 hormone study, has been directly tested for…
Editor's Top Picks
Zinc for the Common Cold: A 2024 Cochrane Review Finds Limited Benefit and Consistent Side Effects
A 2024 Cochrane systematic review of 34 trials (8,526 participants) found zinc does not prevent the common cold and may…
Submit Your Paper →
More form Clinical Updates
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by…
AI transforms radiopharmaceutical discovery and personalizes cancer dosimetry, JMIR reports
Machine learning and generative AI are accelerating radiopharmaceutical discovery and enabling personalized radiation dosing for…
Artemisinin Resistance Surges in East Africa, Threatening Malaria Treatment Efficacy
Artemisinin resistance is expanding geographically across East Africa, threatening the effectiveness of frontline malaria treatments.…
FDA Issues Early Alert Over Non-Sterile BD ChloraPrep Applicators in Medline Convenience Kits
The FDA has issued an early alert regarding BD ChloraPrep Applicators in Medline convenience kits…
Only Half of Eligible Adults Complete Bowel Cancer Screening in England
Health officials in England report that fewer than half of eligible 54-year-olds have completed free…